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1. Introduction 
The effects of prostaglandlns of the E, A and F 
series on the adenylate and guanylate cyclase system 
of various cloned cell lines in culture have been de- 
scribed [l-6 ] . Since the detection of the endo- 
peroxides PGGz and PGHz [7], thromboxane AZ 
[8] and PGIz (prostacyclin) [9-l I], many labora- 
tories worked on the effects of these new prosta- 
glandins on platelet aggregation and platelet adenylate 
cyclase [12-l 81. Little is know however about the 
effects of these prostaglandins oncyclic nucleotide 
levels in other systems. We therefore compared the 
effect of PGIz and 2 endoperoxide analogues 
(U 44069 and U 46619) with the effects of prosta- 
glandins of the A, B, E and F series on CAMP and 
cGMP levels of the murine neuroblastoma cell line 
N4TG3 and the human astrocytoma cell line 1321Nl. 
We show that PGIz is an extremely potent stimulator 
of CAMP accumulation i N4TG3 cells, while it is 
relatively inactive in 132 1Nl cells. Furthermore 
cGMP accumulation isstimulated by PGIz and PGEl 
in the neuroblastoma cell line. 
2. Materials and methods 
2.1. Prostaglandins 
All prostaglandins were a gift from the Upjohn 
Company, MI. 6@H-5,6cwdihydro-PGIz wasob@ined 
from the Carlo Erba institute, Milano, which also 
supplied a sample of PGIl . Stock solutions (10 mM) 
of prostaglandius except PGIz were prepared in 
ethanol and kept at -20°C. PGIz and 6PH-5,6ar 
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dihydro-PG12 were dissolved in cold 0.05 M Tris 
buffer, pH 9.4, immediately before each experiment. 
2.2. Cell culture 
The isolation and growth conditions of human 
astrocytoma cell line 132 lN1 [ 1 ,I 0 ] and the 6- 
thioguanine resistant neuroblastoma cell line N4TG3 
[20,21] have been described. 1321Nl cells were 
obtained from R. B. Clark, Worcester, MA. N4TG3 
cells were from B. Hamprecht, Miinchen. 35 mm 
‘Lux’ plastic dishes were seeded with 1 X 10’ 
(N4TG3) or 2 X lo5 (1321Nl) cells in 2 ml growth 
medium and grown for 3 days. 
2.3. Experimental incubations 
For experimental incubations cells were washed 
with serum free growth medium and challenged with 
prostaglandius for 2 min at 37°C in serum free growth 
medium containing 1 mM isobutyhnethyl xanthine 
(IBMX). Incubations were stopped by aspirating the 
medium and adding 1 ml 5% trichloroacetic acid 
(TCA). The TCA was extracted with water saturated 
ether and used for CAMP and cGMP radloimmunoassay 
without further purification. 
2.4. Cyclic nucleotide determination 
For CAMP and cGMP RIA lo-500 f_d of the 
ether-extracted TCA extract were incubated over- 
night at 0°C with 20 000 cpm ‘251-labeled-2’-0 
succinyl cyclic CAMP or cGMP tyrosine methyl 
ester and CAMP or cGMP antiserum (final dilution, 
I:200 000) in total vol. 2 ml in isotonic phosphate 
buffer, pH 7.4, containing 1 g gelatine/liter. For the 
cGMP RIA the acetylation step in [22] was included. 
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Bound and free “%abe1ed-1igand was separated by 
the addition of 0.2 ml charcoal suspension (Aktivkohle, 
E. Merck, 20 mg/ml phosphate buffer) and immediate 
centrifugation. 
The inhibitor of the binding of 1251-labeled-ligands 
in the CAMP and cGMP RIA, respectively, was 
adsorbed by charcoal treatment, destroyed by beef 
heart phosphodiesterase. S rial dilutions of the TCA 
extracts inhibited the binding to the same degree as 
authentic CAMP or cGMP. Addition of known 
amounts of CAMP or cGMP standards toTCA extracts 
after the ether extraction step showed a complete 
recovery of the added cyclic nucleotides. Cross- 
reactions of both antisera with other nucleotides and 
nucleosides are summarized in table 1. 
3. Results 
3 .l . Effects of PGI, on CAMP 
Stimulation of CAMP accumulation by PGEr in 
N4TG3 cells [21,23] and by PGEr, Ez, A1 and F, 
in 1321Nl cells [l] has been reported. The data of 
fig.1 compare the effects of PGIz and its stable end- 
product 6-keto Fr, with PGEr during a 2 min 
incubation period in both cell lines. While PGI? is a 
more potent stimulator of adenylate cyclase than 
PGEr in N4TG3 cells (EDso 3 nM), its EDSO in 
132 1Nl cells (10 PM) is significantly higher than the 
Table 1 
Cross-reactions of the CAMP and cGMP antiserum with 
various nucleotides and nucleosides 
% Cross-reaction 
Inhibitor CAMP antiserum cCMP antiserum 
3’:5’ CAMP 100 0.01 
3’5’ cIMP 1 3 
3’5’ cGMP < 0.001 100 
Guanosine 
2’:3’ CAMP 
2’:3’ cGMP 
ATP, ADP, AMP 
GTP, GDP, GMP 
Adenosine 
I 
0.004 
< 0.001 < 0.002 
Assay conditions as destibed in 2.4 ; final antiserum dilution 
1:200 000 
I I b I I 
NLTG3 1321Nl 
rr 
Fig.1. The effect of PGE, (o-o-o), PGI, (o-o-e) and 
6-keto F,, (A-A-A) on CAMP accumulation in N4TG3 cells 
(left) and 1321Nl cells (right). Results are means r SD of 
3 dishes assayed in duplicate. 
EDsO measured for PGEr (1 E.~M). 6-Keto F, has 
only small effects on CAMP levels in both cell types. 
At high concentrations the stable PGIz derivative 
6PH-5, 6cudihydro-PGIz stimulates CAMP accumula- 
tion to the same degree as PGIs in both cell lines 
(table 2). Its EDso in N4TG3 cells is however about 
100 times higher than the ED,,, determined for PGIz 
(data not shown). 
3.2. Effects of o ther prostaglandins on CAMP 
Table 2 compares the effects of maximal concen- 
trations of various prostaglandins onthe adenylate 
cyclase of both cell lines. It confirms the data reported 
earlier on PGEr, Ez, Ar and PGF?, stimulated cAh4P 
accumulation i 132 1Nl cells [l] and shows that the 
pattern of prostaglandin stimulation in N4TG3 cells 
is the same as reported for the N4TG3 clone [3]. It 
demonstrates that PGBr is a rather poor stimulator in 
both cell lines and that the 2 stable endoperoxide 
analogues U 44069 and U 44619 have a different 
effect on the CAMP level of the astrocytoma line: 
At high concentration (30 PM) the 9ql larepoxy- 
methano derivative U 44069 has a stimulatory effect, 
while the 1 lo,9o-epoxymethano c mpound U 46619 
is inactive (table 2). In N4TG3 cells both analogues 
have the same, small stimulatory effect on CAMP 
accumulation at 10 PM. 
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Table 2 
Effects of different prostaglandins on CAMP levels in 1321Nl and N4TG3 cells 
% PGE, response 
Prostaglandin 1321Nl ceils (30 PM) N4TG3 cells (10 PM) 
Exp. la Exp. 2a Exp. lb Exp. 2a Exp. 3b 
PGE, 100 * 14 100 f 13 100 f 14 1001: 9 loot 4 
PGE, 101 + 14 89* 9 86* 6 77* 11 60+ 3 
PGA, 83 + 10 66* 6 832 4 75*7 - 
PGB, 26+ 3 22i: 3 44t 2 33i2 - 
PGF,, 9+1 - 36* 2 38*4 - 
PGI, 42* 5 61 f 11 129 f 14 129+ 9 111 i 27 
6-keto Flcu 9+ 1 5* 1 lo+ 1 29+2 - 
6pH 5,6o- 
dihydro-PGI, 46 * 3 38?5 - ill? 8 98-t 11 
U 44069 29+2 - 20? 11 11*1 - 
U 46619 5*1 - ll? 1 lo*1 - 
None 6* 1 6+ 2 4+ 1 4* 1 3* 1 
a n = 4, x f SD, each dish assayed in duplicate 
b n = 3, X + SD, each dish assayed in duplicate 
CAMP accumulation at 30 nM (1321Nl) and 10 rM (N4TG3) prostaglandin con- 
centration is compared. In both cell lines CAMP levels in the presence of PGE, 
were set as 100% for each experiment. Maximal stimulation of CAMP accumulation 
was 398 pmol/mg protein/2 min in 1321Nl cells and varied between 428 and 
617 pmol/mg protein/2 min in N4TG3 cells 
3.3. Effects on cGMP levels 
Figure 2 depicts the effects of PGEr , PGIz and 6 
keto-F,, on cGMP levels in both cell types. While 
there is a barely measurable level of cCMP in the 
astrocytoma cell line (0.3 pmol cCMP/mg protein), 
the basal cGMP level in N4TG3 cells after a 2 min 
incubation period in the presence of 1 mM IBMX was 
20-30-times higher (6.3-10.9 pmoles cGMP/mg 
protein). In the absence of IBMX cGMP and CAMP 
levels were however significantly lower (1.3 pmol 
cGMP/mg protein), confirming the high phospho- 
diesterase activity in N4TG3 cells described [21,23]. 
Furthermore there was no detectable influence of 
any of the prostaglandins on the cGMP level in 
1321 Nl cells (table 3, fig.2) while PGEr and PGIz 
caused a 5--7-fold increase in cGMP levels in N4TG3 
cells at 10 FM. While PGiz had a higher affinity to 
the receptor mediating this effect, the app. V,, 
of PGEr was greater in most experiments (table 3, 
fig.2). In preliminary experiments no stimulation of 
cGMP levels by 10 PM PGIz was found, when 
Krebs-Ringer solution containing 1 inM IBMX [24] 
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Fig.2. The effect of PGE, (o-o-o), PGI, (e - l - l ) and 
6-keto-F,, (b-4-4) on cGMP accumulation in N4TG3 (left) 
and 1321Nl cells (right). Results are the average of 2 dishes, 
or means of 3 dishes f SD assayed in duplicate (N4TG3) or 
single determinations (1321Nl). Note the different scale for 
N4TG3 and 1321Nl results. 
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Table 3 
Effects of various prostaglandms on cCMP levels in 1321Nl and N4TG3 cells 
(pmol cGMP/mg protein/2 min) 
Prostaglandins 1321Nl cells N4TG3 cells 
- 
Exp. la Exp. 2a Exp. lb Exp. 2a Exp. 3c 
PGE, 0.34 f 0.02 0.23 f 0.03 31.1 f 5.0 38.3 f 0.9 55.6 * 4.8 
PGE, 0.37 f 0.02 0.25 + 0.02 9.6 f 1.8 11.0 f 1.3 13.1 f 0.7 
PGA, 0.32 f 0.02 - 7.6 f 2.0 9.9 f 1.6 - 
PGB, 0.36 * 6.04 - 7.0 * 0.8 7.3 f 1.9 - 
PGF, 0.37 f 0.03 - 8.8 * 0.6 9.6kl.O - 
PGI, 0.34 f 0.01 0.29 f 0.03 26.4 f 2.6 39.1 f 2.7 36.7 ?: 4.1 
6-Keto F,& 0.36 f 0.06 - 7.4 f 0.8 8.6 f 0.8 - 
6@H 5,6a- 
dihydroPG1, 0.34 f 0.05 0.32 f $09 - 14.8 f 2.4 14.9 f 1.8 
U 44069 0.37 f 0.04 - 8.2 + 0.3 8.9 * 2.2 - 
U 46619 0.36 f 0.03 - 7.4 * 0.9 9.3 f 1.1 - 
Noned 0.34 0.30 6.3 10.9 8.3 
a n = 4, x r SD, single determinations 
b n = 3, X + SD, single determinations 
c n = 3, X f SD, duplicate determinations 
dn=2 
Experiment numbers refer to the same xperiments as listed in table 2 for the CAMP system 
was used as incubation medium. In the absence of 
calcium cGMP levels in Krebs-Ringer solution were 
even lower. 
4. Discussion 
PGIz has been shown to be a more potent stimu- 
lator of platelet adenylate cyclase than PGEl [ 13-151. 
The main point of this report is to extent this com- 
parison to other adenylate cyclase systems. The data 
of fig.1 and table 2 show that like in the platelets 
PGIz is also in N4TG3 cells a more potent agonist 
than PGE1. The EDso (3 nM) for PGIz in N4TG3 
cells is lo-times lower than in the human platelet 
adenylate cyclase system [ 131. However in 1321Nl 
cells PGI? is substantially less potent than PGE, . 
Beside the difference in affinity (ED,,) of 
various prostaglandins (compare EDso for PGEl in 
both cell lines) and their effects at maximal con- 
centrations (V,,) ( table 2,2-4), the marked 
difference in potency of PGI, found in the 2 cell 
lines, may represent an interesting characteristic of 
different types of prostaglandin receptors. Together 
with the information on antagonists of prostaglandin 
effects [26], on the stereospecificity for different 
prostaglandins (compare the effects of U 44069 and 
U 46619) and binding studies with labeled prosta- 
glandins [3], these data may help to classify multiple 
types of prostaglandin receptors linked to the ade- 
nylate or guanylate cyclase system. 
The data of table 2 confirm the low activity of the 
endoperoxide analogues U 46619 and U 44069 to 
stimulate CAMP accumulation found in rat osteogenic 
sarcoma cells [25]. In contrast to the adenylate 
cyclase inhibiting effect of PGGz in platelets [ 161 
and of PGHz in adipocyte ghosts [ 171 10 E.~M U 44069 
did not alter the stimulation of CAMP or cGMP 
accumulation in N4TG3 cells by 10 nM or 1 PM PGIz 
(data not shown). 
Simultaneous stimulation by PGEl of CAMP and 
cGMP accumulation has been reported [4]. Basal as 
well as stimulated cGMP levels in N4TG3 cells are in 
the same concentration range as described for Nl El 15 
neuroblastoma cells [4] . Our data characterize further 
the receptor mediating the stimulation of cGMP 
accumulation by PGEl and PGEz :the affinity of 
PG12 (EDso 0.2 PM) and PGEl (EDso 2 PM) for this 
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receptor is 100 times lower than in the CAMP system. 
The receptor displays a similar specificity for PGEr 
and PGIa as the receptor which mediates the stimula- 
tion of CAMP accumulation, because at 10 MM only 
PGEr , PGIa and @H-S ,6cu-dihydro-PGIz stimulate 
consistently cGMP levels. In contrast o the CAMP 
system 6/?H-5,6ar-dihydro-PGIz stimulates significantly 
less than PGIa. Preliminary data show that while the 
CAMP accumulation isnot altered by the use of 
Krebs-Ringer solution as incubation medium, no 
stimulation of cGMP levels is observed under these 
conditions. The reason for this observation isunknown. 
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